Pediatrics (Rotavirus Gastroenteritis)

Committee Recommends Routine Use of Vaccine in Infants

Published in Medical Letter on the CDC and FDA, March 2nd, 1998

The U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend routine use of the first vaccine developed to prevent rotavirus gastroenteritis in infants.

The committee will approve the official draft of this recommendation after the rotavirus vaccine is licensed for use by the FDA. Rotavirus gastroenteritis is the most common cause of severe and sometimes fatal diarrhea in children.

The vaccine is intended to be given in three oral doses at 2, 4 and 6 months of age and is compatible with other routine childhood immunizations. It was developed through a Cooperative Research and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1998-03-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry